Cargando…
Baseline cardiac function checkup in patients with gastric or breast cancer receiving trastuzumab or anthracyclines
BACKGROUND: Although trastuzumab and anthracyclines are frequently used to treat breast cancer (BC) and gastric cancer (GC), cardiotoxicity is a serious concern. The cardiac function assessment is recommended at baseline before initiating treatment. However, the prevalence rates of baseline cardiac...
Autores principales: | Ishii, Taisuke, Watanabe, Tomone, Higashi, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844617/ https://www.ncbi.nlm.nih.gov/pubmed/35689469 http://dx.doi.org/10.1002/cam4.4929 |
Ejemplares similares
-
Epidemiology and practice patterns for male breast cancer compared with female breast cancer in Japan
por: Ishii, Taisuke, et al.
Publicado: (2020) -
Differences in the performance of adjuvant chemotherapy between hemodialysis and nonhemodialysis patients
por: Ishii, Taisuke, et al.
Publicado: (2022) -
Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2018) -
An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study
por: Yoodee, Jukapun, et al.
Publicado: (2021) -
BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or Trastuzumab
por: Dobson, Rebecca, et al.
Publicado: (2021)